Attached files
| file | filename |
|---|---|
| S-1/A - Cellectar Biosciences, Inc. | v189973_s1a.htm |
| EX-4.1 - Cellectar Biosciences, Inc. | v189973_ex4-1.htm |
| EX-10.53 - Cellectar Biosciences, Inc. | v189973_ex10-53.htm |
| EX-10.51 - Cellectar Biosciences, Inc. | v189973_ex10-51.htm |
| EX-10.52 - Cellectar Biosciences, Inc. | v189973_ex10-52.htm |
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the
Board of Directors
Novelos
Therapeutics, Inc.
We
consent to the use of our report dated March 23, 2010, relating to the financial
statements of Novelos Therapeutics, Inc. as of December 31, 2009 and 2008 and
for the years then ended in Amendment No. 2 to the Registration Statement on
Form S-1 (No. 333-166744) of Novelos Therapeutics, Inc. We also consent to the
use of our name and the reference to us in the ‘‘Experts’’ section of this
registration statement.
|
/s/
Stowe & Degon LLC
|
|
Westborough,
Massachusetts
|
|
July
6, 2010
|